About
Contact & Profiles
A5093433074
Research Areas
- HIV/AIDS Research and Interventions
- Prenatal Substance Exposure Effects
- HIV, Drug Use, Sexual Risk
- Reproductive Health and Contraception
- Heparin-Induced Thrombocytopenia and Thrombosis
- Pregnancy and Medication Impact
- HIV/AIDS drug development and treatment
- Venous Thromboembolism Diagnosis and Management
- Cerebral Venous Sinus Thrombosis
NHS Greater Glasgow and Clyde
2023-2024
10.1016/s0140-6736(21)01608-1
article
EN
other-oa
The Lancet
2021-08-06
10.1136/bmjsrh-2024-202289
article
EN
BMJ Sexual & Reproductive Health
2024-05-22
Background: In this service evaluation we evaluate the usage of emtricitabine and tenofovir alafenamide (FTC-TAF) in a large Scottish sexual health providing Human Immunodeficiency Virus (HIV) Pre-Exposure Prophylaxis (PrEP) over one-year period (May 2022-May 2023). Purpose: We evaluated use FTC-TAF as it is 30 times more expensive per tablet supply than emtricitabine/tenofovir disoproxil (FTC-TDF). sought to establish: - Number patients initiated on Reasons for initiation Adherence FTC-TAF....
10.1177/09564624231220098
article
EN
International Journal of STD & AIDS
2023-12-05
Coming Soon ...